Stockreport

Takeda Pharmaceuticals presents data analyses for Entyvio in bio-naïve patients for the treatment of UC or CD [Seeking Alpha]

TAKEDA PHARMA  (TKPYY) 
NASDAQ:AMEX Investor Relations: takeda.com/investors
PDF Takeda Pharmaceuticals presents data analyses for Entyvio in bio-naïve patients for the treatment of UC or CD [Read more]